Purdue Pharma (English Wikipedia)

Mitchell, Jerry (26 January 2018). "How the FDA helped pave the way for an opioid epidemic". Clarion Ledger. Jackson MS. Retrieved 12 December 2022.

cnbc.com (Global: 220^th place; English: 155^th place)

"Purdue Pharma, Execs to Pay $634.5 Million Fine in OxyContin Case". Associated Press. 2007-05-10. Archived from the original on 2019-08-21. Retrieved September 21, 2022 – via CNBC.

cnn.com (Global: 28^th place; English: 26^th place)

cnn.com

Chris Isidore (21 October 2020). "OxyContin maker to plead guilty to federal criminal charges, pay $8 billion, and will close the company". CNN. Retrieved 2020-10-23.
A US bankruptcy judge approved Purdue Pharma and Sacklers’ $6 billion settlement agreement with states, Connecticut AG says, CNN, Lauren del Valle, March 10, 2022.
Delouya, Samantha (30 May 2023). "Court grants Sackler family immunity in exchange for $6 billion opioid settlement". CNN.

edition.cnn.com

OxyContin maker to plead guilty to federal criminal charges, pay $8 billion, and will close the company, CNN, 18 August 2020

congress.gov (Global: 730^th place; English: 468^th place)

"H.R.2096 - SACKLER Act". Congress.gov. 19 October 2021. Retrieved 22 August 2023.

ct.gov (Global: 3,566^th place; English: 1,985^th place)

General, Office of the Attorney. "CT Attorney General". www.ct.gov. Archived from the original on 19 December 2006. Retrieved 22 October 2017.
General, Office of the Attorney. "CT Attorney General". www.ct.gov. Archived from the original on 19 December 2006. Retrieved 22 October 2017.

documentcloud.org (Global: 4,633^rd place; English: 2,753^rd place)

Kassie McClung (The Frontier). "Oklahoma'sopioidlawsuitpetition". www.documentcloud.org. Archived from the original on 2019-03-27. Retrieved 2019-03-27.

doi.org (Global: 2^nd place; English: 2^nd place)

Van Zee, Art (February 2009). "The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy". American Journal of Public Health. 99 (2): 221–227. doi:10.2105/AJPH.2007.131714. ISSN 0090-0036. PMC 2622774. PMID 18799767.
Fudin, J.; Raouf, M.; Wegrzyn, E. L. (2016). "OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form". Journal of Pain Research. 9: 609–612. doi:10.2147/JPR.S117219. PMC 5019471. PMID 27660487. In conclusion, the oxycodone CR is well positioned to be dosed every 12 hours as initially demonstrated to and approved by the FDA in 1995.
Cicero TJ, Inciardi JA, Muñoz A (2005). "Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004". Journal of Pain. 6 (10): 662–72. doi:10.1016/j.jpain.2005.05.004. PMID 16202959.

domain-b.com (Global: low place; English: low place)

"domain-b.com : Purdue Pharma fined $634 million for OxyContin deaths; executives punished". www.domain-b.com. July 22, 2007. Archived from the original on 6 February 2010. Retrieved 22 October 2017.

esquire.com (Global: 472^nd place; English: 340^th place)

Glazek, Christopher (2017-10-16). "The Secretive Family Making Billions From the Opioid Crisis". Esquire. Archived from the original on 2019-09-20. Retrieved 2019-09-21.

fiercepharma.com (Global: low place; English: 8,921^st place)

Becker, Zoey (31 May 2023). "With court's blessing, billionaire Sackler family awarded legal protections in Purdue's $6B settlement". Fierce Pharma.

ft.com (Global: 210^th place; English: 157^th place)

"Opioid maker Purdue Pharma agrees $8bn US settlement". Retrieved 2020-10-23.
Crow, David (9 September 2018). "Billionaire Sackler family owns second opioid drugmaker". Financial Times. Archived from the original on September 15, 2018. Retrieved September 15, 2018.
David Crowe (September 8, 2018). "What next for the Sacklers? A pharma dynasty under siege". Financial Times. Archived from the original on March 27, 2019. Retrieved February 24, 2019.

genengnews.com (Global: low place; English: 6,625^th place)

"Purdue Pharma Acquires TrkA Inhibitor Program for Up to $213M+ - GEN". GEN. 8 September 2015. Archived from the original on 23 October 2017. Retrieved 22 October 2017.

heraldnet.com (Global: 6,452^nd place; English: 3,557^th place)

Scott North (February 20, 2017), "Everett's suit against OxyContin maker moves to federal court", Everett Herald, archived from the original on February 28, 2017, retrieved May 31, 2017

hilltopmonitor.com (Global: low place; English: low place)

"OxyContin drugmaker Purdue files for bankruptcy". hilltopmonitor.com. Archived from the original on 2021-03-05. Retrieved 2019-09-19.

hyperallergic.com (Global: 6,997^th place; English: 4,096^th place)

"Elizabeth A. Sackler Supports Nan Goldin in Her Campaign Against OxyContin". Hyperallergic. 2018-01-22. Archived from the original on 2018-01-23. Retrieved 2018-01-23.

latimes.com (Global: 22^nd place; English: 19^th place)

Harriet, Ryan; Girion, Lisa; Glover, Scott (May 5, 2016). "'You want a description of hell?' OxyContin's 12-hour problem". Los Angeles Times. Archived from the original on January 24, 2018. Retrieved October 18, 2017. This is an in-depth series.
‘You Want A Description Of Hell?’ Oxycontin’s 12-Hour Problem, Los Angeles Times, 5 May 2016
Harriet Ryan (January 19, 2017), "City devastated by OxyContin use sues Purdue Pharma, claims drugmaker put profits over citizens' welfare", Los Angeles Times, archived from the original on June 1, 2017, retrieved May 31, 2017

mass.gov (Global: 4,670^th place; English: 2,640^th place)

Internal memorandum, Kirk Ogrosky
Internal Memorandum, Kirk Ogrosky

mysanantonio.com (Global: 2,802^nd place; English: 1,579^th place)

Paul Schott (March 2019). "FDA approves Purdue Pharma subsidiary's ADHD drug". Mysa. Archived from the original on 2019-03-06. Retrieved 2019-03-05.

nbcnews.com (Global: 137^th place; English: 101^st place)

Strickler, Laura (9 September 2019). "Opioid talks break down; Purdue owners balk at paying $4.5 billion". Associated Press. Archived from the original on 2019-09-21. Retrieved September 21, 2022 – via NBC News.
First it sold Oxycontin, then pharma company saw market for anti-addiction drug, suit says, NBC News, 2 February 2019.
"Purdue Pharma offers $10-12B to settle 2,000+ opioid lawsuits". NBC News. 27 August 2019. Archived from the original on 2019-08-27. Retrieved 2019-08-27.
"They're the first family of pharma. And now they're being sued". NBC News. 16 June 2018. Archived from the original on 2019-09-11. Retrieved 2019-09-19.
"N.Y. officials: We found $1 billion in Sackler family wire transfers". NBC News. 14 September 2019. Archived from the original on 2019-09-20. Retrieved 2019-09-21.

newyorker.com (Global: 146^th place; English: 110^th place)

Keefe, Patrick Radden (2017-10-23). "The Family That Built an Empire of Pain". The New Yorker. ISSN 0028-792X. Archived from the original on 2018-01-22. Retrieved 2018-01-19.
The Family That Built an Empire of Pain, New Yorker, 23 October 2017
Keefe, Patrick Radden (October 2017). "The Family That Built an Empire of Pain: The Sackler dynasty's ruthless marketing of painkillers has generated billions of dollars—and millions of addicts". The New Yorker. A Reporter at Large. Archived from the original on January 22, 2018. Retrieved October 26, 2017. According to Forbes, the Sacklers are now one of America's richest families, with a collective net worth of thirteen billion dollars—more than the Rockefellers or the Mellons... While the Sacklers are interviewed regularly on the subject of their generosity, they almost never speak publicly about the family business, Purdue Pharma—a privately held company, based in Stamford, Connecticut, that developed the prescription painkiller OxyContin. Indepth-analysis
The Family that Built an Empire of pain. The New Yorker, 23 October 2017
"The Family That Built an Empire of Pain". The New Yorker. 23 October 2017. Archived from the original on 2018-01-22. Retrieved 2017-10-26.
Keefe, Patrick Radden (23 October 2017). "The Family That Built an Empire of Pain". The New Yorker. Archived from the original on 22 January 2018. Retrieved 27 March 2019 – via www.newyorker.com.
"New Yorker Sackler Article". newyorker.com. October 23, 2017. Archived from the original on January 22, 2018. Retrieved October 17, 2018.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Van Zee, Art (February 2009). "The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy". American Journal of Public Health. 99 (2): 221–227. doi:10.2105/AJPH.2007.131714. ISSN 0090-0036. PMC 2622774. PMID 18799767.
Fudin, J.; Raouf, M.; Wegrzyn, E. L. (2016). "OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form". Journal of Pain Research. 9: 609–612. doi:10.2147/JPR.S117219. PMC 5019471. PMID 27660487. In conclusion, the oxycodone CR is well positioned to be dosed every 12 hours as initially demonstrated to and approved by the FDA in 1995.
Hirsch R (2017). "The Opioid Epidemic: It's Time to Place Blame Where It Belongs". Missouri Medicine. 114 (2): 82–90. PMC 6140023. PMID 30228543.
Cicero TJ, Inciardi JA, Muñoz A (2005). "Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004". Journal of Pain. 6 (10): 662–72. doi:10.1016/j.jpain.2005.05.004. PMID 16202959.

ncbi.nlm.nih.gov

Van Zee, Art (February 2009). "The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy". American Journal of Public Health. 99 (2): 221–227. doi:10.2105/AJPH.2007.131714. ISSN 0090-0036. PMC 2622774. PMID 18799767.
Fudin, J.; Raouf, M.; Wegrzyn, E. L. (2016). "OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form". Journal of Pain Research. 9: 609–612. doi:10.2147/JPR.S117219. PMC 5019471. PMID 27660487. In conclusion, the oxycodone CR is well positioned to be dosed every 12 hours as initially demonstrated to and approved by the FDA in 1995.
Hirsch R (2017). "The Opioid Epidemic: It's Time to Place Blame Where It Belongs". Missouri Medicine. 114 (2): 82–90. PMC 6140023. PMID 30228543.

no-more-tears.org (Global: low place; English: low place)

Janssen (December 9, 1998). "Supply Agreement" (PDF). PF Laboratories contract. Retrieved May 13, 2025.
Whoriskey, Peter (March 26, 2020). "How Johnson & Johnson companies used a 'super poppy' to make narcotics for America's most abused opioid pills" (PDF). The Washington Post. Retrieved May 13, 2025.

npr.org (Global: 92^nd place; English: 72^nd place)

Mann, Brian (11 September 2019). "Purdue Pharma Reaches Tentative Deal To Settle Thousands Of Opioid Lawsuits". NPR. Archived from the original on 2019-09-21. Retrieved 2019-09-21.
"U.S. City Sues OxyContin Maker For Contributing To Opioid Crisis", Morning Edition, NPR, February 3, 2017, archived from the original on March 13, 2018, retrieved April 5, 2018
Gonzales, Richard (13 September 2019). "New York AG Says Sacklers Transferred $1B From Pharma Accounts To Themselves". NPR. Archived from the original on 2019-09-21. Retrieved 2019-09-21.
Mann, Brian (3 May 2021). "Sackler Family Bid For Opioid Immunity Is Fought By 24 States And D.C. : NPR". NPR. NPR. Retrieved 2021-05-05.
Mann, Brian (3 March 2022). "Purdue Pharma and the Sackler family reach $6 billion OxyContin settlement : NPR". npr.org. Retrieved 2024-06-29.

nytimes.com (Global: 7^th place; English: 7^th place)

Roberts, Sam (19 July 2017). "Opinion - Raymond Sackler, Psychopharmacology Pioneer and Philanthropist, Dies at 97". The New York Times. Archived from the original on 28 December 2017. Retrieved 11 February 2018.
Hoffman, Jan; Walsh, Mary Williams (2019-09-15). "Purdue Pharma, Maker of OxyContin, Files for Bankruptcy". The New York Times. ISSN 0362-4331. Archived from the original on 2019-09-21. Retrieved 2019-09-21.
Meier, Barry (May 10, 2007). "In Guilty Plea, OxyContin Maker to Pay $600 Million". The New York Times. Archived from the original on October 27, 2017. Retrieved October 26, 2017.
"McKinsey Advised Purdue Pharma How to 'Turbocharge' Opioid Sales, Lawsuit Says". The New York Times. 2019-02-01.
"McKinsey Proposed Paying Pharmacy Companies Rebates for OxyContin Overdoses". The New York Times. 2020-11-27.
"McKinsey Proposed Paying Pharmacy Companies Rebates for OxyContin Overdoses". The New York Times. 2020-11-27.
"McKinsey Settles for Nearly $600 Million Over Role in Opioid Crisis". The New York Times. 2021-02-03.
"McKinsey Settles for Nearly $600 Million Over Role in Opioid Crisis". The New York Times. 2021-02-03.
Meier, Barry (29 May 2018). "Origins of an Epidemic: Purdue Pharma Knew Its Opioids Were Widely Abused". The New York Times. Archived from the original on 30 May 2018. Retrieved 30 May 2018.
Barry Meier (May 11, 2007). "In Guilty Plea, OxyContin Maker to Pay $600 Million". The New York Times. Archived from the original on 2015-06-11.
Hoffman, Jan (2019-03-26). "Purdue Pharma and Sacklers Reach $270 Million Settlement in Opioid Lawsuit". The New York Times. ISSN 0362-4331. Archived from the original on 2019-03-27. Retrieved 2019-03-27.
Hoffman, Jan (August 27, 2019). "Sacklers Would Give Up Ownership of Purdue Pharma Under Settlement Proposal". The New York Times. Archived from the original on August 28, 2019. Retrieved August 28, 2019.
Hoffman, Jan; Hakim, Danny (16 December 2019). "Purdue Pharma Payments to Sackler Family Soared Amid Opioid Crisis". The New York Times. Archived from the original on 2019-12-18. Retrieved 2019-12-18.
Hoffman, Jan (2021-12-17). "Judge Overturns Purdue Pharma's Opioid Settlement". The New York Times. ISSN 0362-4331. Retrieved 2022-01-01.
VanSickle, Abbie (2023-08-10). "Supreme Court Pauses Purdue Pharma Bankruptcy Deal". The New York Times. Retrieved 2023-08-10.
VanSickle, Abbie (June 27, 2024). "Supreme Court Jeopardizes Opioid Deal, Rejecting Protections for Sacklers". New York TImes. Retrieved August 21, 2024.

opiateaddictionsupport.com (Global: low place; English: low place)

"FRONTLINE Documentary "Chasing Heroin" Investigates the Opioid Epidemic". 27 February 2016. Archived from the original on 2016-03-07. Retrieved 2016-03-04.

purdue.edu (Global: 850^th place; English: 625^th place)

Service, Purdue News. "Purdue University statement re: Purdue Pharma". www.purdue.edu. Archived from the original on 2019-09-21. Retrieved 2019-09-21.

purduepharma.com (Global: low place; English: low place)

"Confirmed Plan of Reorganization Facilitates Creation of New Company – 'Knoa Pharma'". Purdue. 3 September 2021. Retrieved September 21, 2022.
"About Purdue Pharma L.P." www.purduepharma.com. Archived from the original on 6 September 2015. Retrieved 22 October 2017.
"About Purdue Pharma L.P." Archived from the original on September 6, 2015. Retrieved September 8, 2015.

reuters.com (Global: 49^th place; English: 47^th place)

"OxyContin maker Purdue Pharma files for bankruptcy protection". Reuters. 2019-09-17. Archived from the original on 2019-09-21. Retrieved 2019-09-21.
Knauth, Dietrich (2023-07-25). "Purdue Pharma bankruptcy can proceed despite potential US Supreme Court appeal". Reuters. Retrieved 2023-08-04.
Bellon, Tina (15 May 2018). "U.S. state lawsuits against Purdue Pharma over opioid epidemic mount". Reuters. Archived from the original on 14 June 2018. Retrieved 5 June 2018.
Kruzel, John; Chung, Andrew (2023-08-10). "US Supreme Court to scrutinize Purdue Pharma bankruptcy settlement". Reuters. Retrieved 2023-08-10.

sackleract.org (Global: low place; English: low place)

"SACKLER ACT". sackleract.org. Archived from the original on 2021-06-29. Retrieved 2021-06-29.

semafor.com (Global: low place; English: low place)

At least 20 institutions have now dropped the Sackler name, Semafor, 17 May 2023.

si.edu (Global: 340^th place; English: 295^th place)

Smithsonian Institution: Gray's Glycerine Tonic Comp. description

slate.com (Global: 259^th place; English: 188^th place)

Slate, The Sacklers Get to Walk Away, Mary Harris, March 21, 2022. The interview with NPR's Brian Mann is "condensed and edited for clarity."

stamfordadvocate.com (Global: 9,464^th place; English: 5,313^th place)

Schott, Paul (June 22, 2017). "Purdue Pharma appoints new CEO". Stamford Advocate. Archived from the original on May 21, 2019. Retrieved May 22, 2019.
Schott, Paul (April 7, 2019). "Sacklers quit Purdue Pharma board amid shifts for OxyContin maker". Stamford Advocate. Archived from the original on May 28, 2019. Retrieved May 22, 2019.

statnews.com (Global: 8,771^st place; English: 5,253^rd place)

The man at the center of the secret OxyContin files, STAT, 12 May 2016

thefix.com (Global: low place; English: 8,239^th place)

Victoria Kim (November 3, 2017). "The Secretive Billionaire Family Behind The Rise Of Oxycontin". The Fix. Archived from the original on February 23, 2019. Retrieved February 22, 2019.

theguardian.com (Global: 12^th place; English: 11^th place)

Purdue Pharma escaped serious charges over opioid in 2006, memo shows, The Guardian, 19 August 2020
"Sackler Blood Money disgraces museums". The Guardian. February 16, 2018. Archived from the original on October 17, 2018. Retrieved October 17, 2018.

thehill.com (Global: 476^th place; English: 282^nd place)

Williams, Jordan (2021-03-19). "Democrats unveil bill to prevent members of the Sackler family from evading lawsuits through bankruptcy". The Hill. Retrieved 2021-05-17.
"Maloney presses for action on bill focused on accountability in opioid crisis". The Hill. 8 June 2021. Retrieved 2021-06-29.

uconn.edu (Global: 5,165^th place; English: 3,393^rd place)

opencommons.uconn.edu

Evaluating Nondebtor Releases: How Purdue PharmaEmphasizes the Need for Congress to Resolve the Decades-Long Debate, Connecticut Law review, June 2023

usatoday.com (Global: 41^st place; English: 34^th place)

usatoday.com

Sue Lindsey, (May 11, 2007) OxyContin Maker, Execs Guilty of Deceit Archived 2012-09-11 at the Wayback Machine USA Today reproducing and Associated Press report
Moritz, John C. "6 states sue maker of OxyContin as they battle expenses, human costs of opioid crisis". USA Today. Corpus Christi (Texas) Caller Times. Archived from the original on 28 May 2018. Retrieved 5 June 2018.
Mulvihill, Geoff (15 September 2019). "OxyContin maker Purdue Pharma files for bankruptcy as part of opioids settlement". USA Today. Archived from the original on 16 September 2019. Retrieved 16 September 2019.

usatoday30.usatoday.com

"Kentucky sues makers of OxyContin". USA Today. Archived from the original on 14 August 2016. Retrieved 22 October 2017.

wbur.org (Global: 2,911^th place; English: 1,596^th place)

WBUR Boston, Massachusetts, Suit: Patients Who Used Purdue's Discount Cards Were More Likely To Get Hooked On OxyContin, Christine Willmsen, Feb. 1, 2019. This article includes graph which shows with and without OxyContin "Savings Card."

web.archive.org (Global: 1^st place; English: 1^st place)

Glazek, Christopher (2017-10-16). "The Secretive Family Making Billions From the Opioid Crisis". Esquire. Archived from the original on 2019-09-20. Retrieved 2019-09-21.
Keefe, Patrick Radden (2017-10-23). "The Family That Built an Empire of Pain". The New Yorker. ISSN 0028-792X. Archived from the original on 2018-01-22. Retrieved 2018-01-19.
Roberts, Sam (19 July 2017). "Opinion - Raymond Sackler, Psychopharmacology Pioneer and Philanthropist, Dies at 97". The New York Times. Archived from the original on 28 December 2017. Retrieved 11 February 2018.
"Purdue Pharma, Execs to Pay $634.5 Million Fine in OxyContin Case". Associated Press. 2007-05-10. Archived from the original on 2019-08-21. Retrieved September 21, 2022 – via CNBC.
Strickler, Laura (9 September 2019). "Opioid talks break down; Purdue owners balk at paying $4.5 billion". Associated Press. Archived from the original on 2019-09-21. Retrieved September 21, 2022 – via NBC News.
Mann, Brian (11 September 2019). "Purdue Pharma Reaches Tentative Deal To Settle Thousands Of Opioid Lawsuits". NPR. Archived from the original on 2019-09-21. Retrieved 2019-09-21.
"OxyContin maker Purdue Pharma files for bankruptcy protection". Reuters. 2019-09-17. Archived from the original on 2019-09-21. Retrieved 2019-09-21.
Hoffman, Jan; Walsh, Mary Williams (2019-09-15). "Purdue Pharma, Maker of OxyContin, Files for Bankruptcy". The New York Times. ISSN 0362-4331. Archived from the original on 2019-09-21. Retrieved 2019-09-21.
Service, Purdue News. "Purdue University statement re: Purdue Pharma". www.purdue.edu. Archived from the original on 2019-09-21. Retrieved 2019-09-21.
"About Purdue Pharma L.P." www.purduepharma.com. Archived from the original on 6 September 2015. Retrieved 22 October 2017.
"Elizabeth A. Sackler Supports Nan Goldin in Her Campaign Against OxyContin". Hyperallergic. 2018-01-22. Archived from the original on 2018-01-23. Retrieved 2018-01-23.
"About Purdue Pharma L.P." Archived from the original on September 6, 2015. Retrieved September 8, 2015.
"Purdue Pharma Acquires TrkA Inhibitor Program for Up to $213M+ - GEN". GEN. 8 September 2015. Archived from the original on 23 October 2017. Retrieved 22 October 2017.
Meier, Barry (May 10, 2007). "In Guilty Plea, OxyContin Maker to Pay $600 Million". The New York Times. Archived from the original on October 27, 2017. Retrieved October 26, 2017.
Harriet, Ryan; Girion, Lisa; Glover, Scott (May 5, 2016). "'You want a description of hell?' OxyContin's 12-hour problem". Los Angeles Times. Archived from the original on January 24, 2018. Retrieved October 18, 2017. This is an in-depth series.
Keefe, Patrick Radden (October 2017). "The Family That Built an Empire of Pain: The Sackler dynasty's ruthless marketing of painkillers has generated billions of dollars—and millions of addicts". The New Yorker. A Reporter at Large. Archived from the original on January 22, 2018. Retrieved October 26, 2017. According to Forbes, the Sacklers are now one of America's richest families, with a collective net worth of thirteen billion dollars—more than the Rockefellers or the Mellons... While the Sacklers are interviewed regularly on the subject of their generosity, they almost never speak publicly about the family business, Purdue Pharma—a privately held company, based in Stamford, Connecticut, that developed the prescription painkiller OxyContin. Indepth-analysis
"Sackler family 'funnelled cash into Swiss banks'". BBC News. September 14, 2019. Archived from the original on September 16, 2019. Retrieved September 19, 2019.
Crow, David (9 September 2018). "Billionaire Sackler family owns second opioid drugmaker". Financial Times. Archived from the original on September 15, 2018. Retrieved September 15, 2018.
Victoria Kim (November 3, 2017). "The Secretive Billionaire Family Behind The Rise Of Oxycontin". The Fix. Archived from the original on February 23, 2019. Retrieved February 22, 2019.
Paul Schott (March 2019). "FDA approves Purdue Pharma subsidiary's ADHD drug". Mysa. Archived from the original on 2019-03-06. Retrieved 2019-03-05.
Schott, Paul (June 22, 2017). "Purdue Pharma appoints new CEO". Stamford Advocate. Archived from the original on May 21, 2019. Retrieved May 22, 2019.
David Crowe (September 8, 2018). "What next for the Sacklers? A pharma dynasty under siege". Financial Times. Archived from the original on March 27, 2019. Retrieved February 24, 2019.
Schott, Paul (April 7, 2019). "Sacklers quit Purdue Pharma board amid shifts for OxyContin maker". Stamford Advocate. Archived from the original on May 28, 2019. Retrieved May 22, 2019.
2007 US v. Purdue Frederick [i.bnet.com/blogs/purdue-agreed-facts.pdf plea agreement order] for the conviction of Purdue Frederick and its employees Michael Friedman, Howard Udell, and Paul Goldenbaum. Archived on February 1, 2022, retrieved ebenda.
"The Family That Built an Empire of Pain". The New Yorker. 23 October 2017. Archived from the original on 2018-01-22. Retrieved 2017-10-26.
"FRONTLINE Documentary "Chasing Heroin" Investigates the Opioid Epidemic". 27 February 2016. Archived from the original on 2016-03-07. Retrieved 2016-03-04.
Keefe, Patrick Radden (23 October 2017). "The Family That Built an Empire of Pain". The New Yorker. Archived from the original on 22 January 2018. Retrieved 27 March 2019 – via www.newyorker.com.
Smith, Jason. "Kingpins: OxyContin, Heroin, and the Sackler-Sinaloa Connection". Archived from the original on 7 March 2016. Retrieved 4 March 2016.
Meier, Barry (29 May 2018). "Origins of an Epidemic: Purdue Pharma Knew Its Opioids Were Widely Abused". The New York Times. Archived from the original on 30 May 2018. Retrieved 30 May 2018.
General, Office of the Attorney. "CT Attorney General". www.ct.gov. Archived from the original on 19 December 2006. Retrieved 22 October 2017.
General, Office of the Attorney. "CT Attorney General". www.ct.gov. Archived from the original on 19 December 2006. Retrieved 22 October 2017.
Sue Lindsey, (May 11, 2007) OxyContin Maker, Execs Guilty of Deceit Archived 2012-09-11 at the Wayback Machine USA Today reproducing and Associated Press report
Barry Meier (May 11, 2007). "In Guilty Plea, OxyContin Maker to Pay $600 Million". The New York Times. Archived from the original on 2015-06-11.
"domain-b.com : Purdue Pharma fined $634 million for OxyContin deaths; executives punished". www.domain-b.com. July 22, 2007. Archived from the original on 6 February 2010. Retrieved 22 October 2017.
"Kentucky sues makers of OxyContin". USA Today. Archived from the original on 14 August 2016. Retrieved 22 October 2017.
"Kentucky settles lawsuit with OxyContin maker for $24 million". CBS News. 23 December 2015. Archived from the original on 2016-04-30. Retrieved 2016-05-02.
Harriet Ryan (January 19, 2017), "City devastated by OxyContin use sues Purdue Pharma, claims drugmaker put profits over citizens' welfare", Los Angeles Times, archived from the original on June 1, 2017, retrieved May 31, 2017
Scott North (February 20, 2017), "Everett's suit against OxyContin maker moves to federal court", Everett Herald, archived from the original on February 28, 2017, retrieved May 31, 2017
"U.S. City Sues OxyContin Maker For Contributing To Opioid Crisis", Morning Edition, NPR, February 3, 2017, archived from the original on March 13, 2018, retrieved April 5, 2018
Bellon, Tina (15 May 2018). "U.S. state lawsuits against Purdue Pharma over opioid epidemic mount". Reuters. Archived from the original on 14 June 2018. Retrieved 5 June 2018.
Moritz, John C. "6 states sue maker of OxyContin as they battle expenses, human costs of opioid crisis". USA Today. Corpus Christi (Texas) Caller Times. Archived from the original on 28 May 2018. Retrieved 5 June 2018.
"Family behind OxyContin maker engineered opioid crisis, Massachusetts AG says". CBS News. 24 January 2019. Archived from the original on 27 January 2019. Retrieved 2019-01-28.
Kassie McClung (The Frontier). "Oklahoma'sopioidlawsuitpetition". www.documentcloud.org. Archived from the original on 2019-03-27. Retrieved 2019-03-27.
Hoffman, Jan (2019-03-26). "Purdue Pharma and Sacklers Reach $270 Million Settlement in Opioid Lawsuit". The New York Times. ISSN 0362-4331. Archived from the original on 2019-03-27. Retrieved 2019-03-27.
"Sackler drug firm settles opioid lawsuit". BBC News. March 26, 2019. Archived from the original on March 28, 2019. Retrieved 2019-03-28.
"New Yorker Sackler Article". newyorker.com. October 23, 2017. Archived from the original on January 22, 2018. Retrieved October 17, 2018.
"Sackler Blood Money disgraces museums". The Guardian. February 16, 2018. Archived from the original on October 17, 2018. Retrieved October 17, 2018.
"Artists Protest Sackler Family Through Museums That Bear Their Name". Bloomberg. 6 March 2019. Archived from the original on 2019-04-16. Retrieved 2019-04-16.
"Purdue Pharma offers $10-12B to settle 2,000+ opioid lawsuits". NBC News. 27 August 2019. Archived from the original on 2019-08-27. Retrieved 2019-08-27.
Hoffman, Jan (August 27, 2019). "Sacklers Would Give Up Ownership of Purdue Pharma Under Settlement Proposal". The New York Times. Archived from the original on August 28, 2019. Retrieved August 28, 2019.
Mulvihill, Geoff (15 September 2019). "OxyContin maker Purdue Pharma files for bankruptcy as part of opioids settlement". USA Today. Archived from the original on 16 September 2019. Retrieved 16 September 2019.
"They're the first family of pharma. And now they're being sued". NBC News. 16 June 2018. Archived from the original on 2019-09-11. Retrieved 2019-09-19.
"OxyContin drugmaker Purdue files for bankruptcy". hilltopmonitor.com. Archived from the original on 2021-03-05. Retrieved 2019-09-19.
Gonzales, Richard (13 September 2019). "New York AG Says Sacklers Transferred $1B From Pharma Accounts To Themselves". NPR. Archived from the original on 2019-09-21. Retrieved 2019-09-21.
"N.Y. officials: We found $1 billion in Sackler family wire transfers". NBC News. 14 September 2019. Archived from the original on 2019-09-20. Retrieved 2019-09-21.
Hoffman, Jan; Hakim, Danny (16 December 2019). "Purdue Pharma Payments to Sackler Family Soared Amid Opioid Crisis". The New York Times. Archived from the original on 2019-12-18. Retrieved 2019-12-18.
"SACKLER ACT". sackleract.org. Archived from the original on 2021-06-29. Retrieved 2021-06-29.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Keefe, Patrick Radden (2017-10-23). "The Family That Built an Empire of Pain". The New Yorker. ISSN 0028-792X. Archived from the original on 2018-01-22. Retrieved 2018-01-19.
Van Zee, Art (February 2009). "The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy". American Journal of Public Health. 99 (2): 221–227. doi:10.2105/AJPH.2007.131714. ISSN 0090-0036. PMC 2622774. PMID 18799767.
Hoffman, Jan; Walsh, Mary Williams (2019-09-15). "Purdue Pharma, Maker of OxyContin, Files for Bankruptcy". The New York Times. ISSN 0362-4331. Archived from the original on 2019-09-21. Retrieved 2019-09-21.
Keefe, Patrick Radden (2021). Empire of Pain: The Secret History of the Sackler Dynasty (First ed.). London: Picador. pp. 272–284. ISBN 978-1-5290-6307-3. OCLC 1249442332.
Hoffman, Jan (2019-03-26). "Purdue Pharma and Sacklers Reach $270 Million Settlement in Opioid Lawsuit". The New York Times. ISSN 0362-4331. Archived from the original on 2019-03-27. Retrieved 2019-03-27.
Hoffman, Jan (2021-12-17). "Judge Overturns Purdue Pharma's Opioid Settlement". The New York Times. ISSN 0362-4331. Retrieved 2022-01-01.

yahoo.com (Global: 38^th place; English: 40^th place)

finance.yahoo.com

Balsamo, Michael; Mulvihill, Geoff (21 October 2020). "US officials: OxyContin maker to plead to 3 criminal charges". finance.yahoo.com. Retrieved 2020-10-21.

Purdue Pharma (English Wikipedia)

addictionunscripted.com (Global: low place; English: low place)

apnews.com (Global: 129th place; English: 89th place)

archive.org (Global: 6th place; English: 6th place)

bbc.com (Global: 20th place; English: 30th place)

bloomberg.com (Global: 99th place; English: 77th place)

cbsnews.com (Global: 108th place; English: 80th place)

cdc.gov (Global: 218th place; English: 212th place)

clarionledger.com (Global: 4,272nd place; English: 2,271st place)

cnbc.com (Global: 220th place; English: 155th place)

cnn.com (Global: 28th place; English: 26th place)

cnn.com

edition.cnn.com

congress.gov (Global: 730th place; English: 468th place)

ct.gov (Global: 3,566th place; English: 1,985th place)

documentcloud.org (Global: 4,633rd place; English: 2,753rd place)

doi.org (Global: 2nd place; English: 2nd place)

domain-b.com (Global: low place; English: low place)

esquire.com (Global: 472nd place; English: 340th place)

fiercepharma.com (Global: low place; English: 8,921st place)

ft.com (Global: 210th place; English: 157th place)

genengnews.com (Global: low place; English: 6,625th place)

heraldnet.com (Global: 6,452nd place; English: 3,557th place)

hilltopmonitor.com (Global: low place; English: low place)

hyperallergic.com (Global: 6,997th place; English: 4,096th place)

latimes.com (Global: 22nd place; English: 19th place)

mass.gov (Global: 4,670th place; English: 2,640th place)

mysanantonio.com (Global: 2,802nd place; English: 1,579th place)

nbcnews.com (Global: 137th place; English: 101st place)

newyorker.com (Global: 146th place; English: 110th place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

no-more-tears.org (Global: low place; English: low place)

npr.org (Global: 92nd place; English: 72nd place)

nytimes.com (Global: 7th place; English: 7th place)

opiateaddictionsupport.com (Global: low place; English: low place)

purdue.edu (Global: 850th place; English: 625th place)

purduepharma.com (Global: low place; English: low place)

reuters.com (Global: 49th place; English: 47th place)

sackleract.org (Global: low place; English: low place)

semafor.com (Global: low place; English: low place)

si.edu (Global: 340th place; English: 295th place)

slate.com (Global: 259th place; English: 188th place)

stamfordadvocate.com (Global: 9,464th place; English: 5,313th place)

statnews.com (Global: 8,771st place; English: 5,253rd place)

thefix.com (Global: low place; English: 8,239th place)

theguardian.com (Global: 12th place; English: 11th place)

thehill.com (Global: 476th place; English: 282nd place)

uconn.edu (Global: 5,165th place; English: 3,393rd place)

opencommons.uconn.edu

usatoday.com (Global: 41st place; English: 34th place)

usatoday.com

usatoday30.usatoday.com

wbur.org (Global: 2,911th place; English: 1,596th place)

web.archive.org (Global: 1st place; English: 1st place)

worldcat.org (Global: 5th place; English: 5th place)

search.worldcat.org

yahoo.com (Global: 38th place; English: 40th place)

finance.yahoo.com

apnews.com (Global: 129^th place; English: 89^th place)

archive.org (Global: 6^th place; English: 6^th place)

bbc.com (Global: 20^th place; English: 30^th place)

bloomberg.com (Global: 99^th place; English: 77^th place)

cbsnews.com (Global: 108^th place; English: 80^th place)

cdc.gov (Global: 218^th place; English: 212^th place)

clarionledger.com (Global: 4,272^nd place; English: 2,271^st place)

cnbc.com (Global: 220^th place; English: 155^th place)

cnn.com (Global: 28^th place; English: 26^th place)

congress.gov (Global: 730^th place; English: 468^th place)

ct.gov (Global: 3,566^th place; English: 1,985^th place)

documentcloud.org (Global: 4,633^rd place; English: 2,753^rd place)

doi.org (Global: 2^nd place; English: 2^nd place)

esquire.com (Global: 472^nd place; English: 340^th place)

fiercepharma.com (Global: low place; English: 8,921^st place)

ft.com (Global: 210^th place; English: 157^th place)

genengnews.com (Global: low place; English: 6,625^th place)

heraldnet.com (Global: 6,452^nd place; English: 3,557^th place)

hyperallergic.com (Global: 6,997^th place; English: 4,096^th place)

latimes.com (Global: 22^nd place; English: 19^th place)

mass.gov (Global: 4,670^th place; English: 2,640^th place)

mysanantonio.com (Global: 2,802^nd place; English: 1,579^th place)

nbcnews.com (Global: 137^th place; English: 101^st place)

newyorker.com (Global: 146^th place; English: 110^th place)

nih.gov (Global: 4^th place; English: 4^th place)

npr.org (Global: 92^nd place; English: 72^nd place)

nytimes.com (Global: 7^th place; English: 7^th place)

purdue.edu (Global: 850^th place; English: 625^th place)

reuters.com (Global: 49^th place; English: 47^th place)

si.edu (Global: 340^th place; English: 295^th place)

slate.com (Global: 259^th place; English: 188^th place)

stamfordadvocate.com (Global: 9,464^th place; English: 5,313^th place)

statnews.com (Global: 8,771^st place; English: 5,253^rd place)

thefix.com (Global: low place; English: 8,239^th place)

theguardian.com (Global: 12^th place; English: 11^th place)

thehill.com (Global: 476^th place; English: 282^nd place)

uconn.edu (Global: 5,165^th place; English: 3,393^rd place)

usatoday.com (Global: 41^st place; English: 34^th place)

wbur.org (Global: 2,911^th place; English: 1,596^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

worldcat.org (Global: 5^th place; English: 5^th place)

yahoo.com (Global: 38^th place; English: 40^th place)